Enfusion To Present at Upcoming Investor Events

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)-- Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced that Enfusion’s Chief Financial Officer, Brad Herring, and Chief Operating Officer, Neal Pawar, will participate at the following investor events:

• Wells Fargo 8th Annual TMT Summit on Tuesday, December 3, 2024
• UBS Global Technology and AI Conference on Wednesday, December 4, 2024

Live audio webcasts and archived replays of the events will be available in the Events & Presentations section of the Enfusion Investor Relations website at http://ir.enfusion.com.

About Enfusion

Enfusion's investment management software-as-a-service platform removes traditional information boundaries, uniting front-, middle- and back-office teams on one system. Through its software, analytics, and middle/back-office managed services, Enfusion creates enterprise-wide cultures of real-time, data-driven intelligence and collaboration boosting agility and powering growth. Enfusion partners with over 850 investment managers from 9 global offices spanning four continents.

Source: Enfusion, Inc.
Source Code: ENFN-IR

View source version on businesswire.com: https://www.businesswire.com/news/home/20241119246594/en/

Investors
Bill Wright
[email protected]

Media
[email protected]

Source: Enfusion, Inc.

You May Also Be Interested In

• Oshkosh Defense Highlights Proven, Adaptable Tactical Mobility Solutions for Europe at Eurosatory 2026
• Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026
• OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 2026